A client engaged Allucent to prepare a food-effect study protocol, analyze interim PK data, and author a clinical information amendment for submission to regulatory authorities. The conduct and reporting of PK results of the food-effect study was on critical path to initiation of a Phase 2 clinical study. The challenge for the client was that the protocol, PK data analysis, and PK clinical information amendment for regulatory submission needed to be prepared in a very short timeframe.
Interim Pharmacokinetic Analysis to Enable Rapid Decision Making

Featured Content

Blog
ICH E11A: Key Features and Implications of the Pediatric Extrapolation Guideline
Read More

Infographic
Shifting Frontiers: The Expansion of Cell & Gene Therapies into Autoimmune Disease
Read More

Blog
Rare Disease Clinical Trials: Challenges, Strategies, and Solutions for Success
Listen Now
View All Resources